Oral Drug Delivery Resources
-
Early Solid Form Screening To Guide Drug Development
Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.
-
Driving Sustainability In Spray Drying Through Enabling Technologies
By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.
-
Microphysiological Systems: Closing The Gap Between Models And Medicine
9/2/2025
Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.
-
The Role Of Micronization In The Journey To Drug Product Development
Micronization is an incredibly important step of the process of transitioning a compound from initial discovery into the clinic. Learn more about the key benefits of micronization.
-
Reshaping Drug Development With 3D Screen Printing
8/15/2025
Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.
-
Achieving New Heights By Expanding Services, Talent, And Facilities
4/20/2023
As you aim to reduce costs and ensure on-time delivery, discover the opportunities for drug formulation and commercial supply that can advance your therapy to the clinic and beyond.
-
Recent Innovations And Enhancements To Pharmaceutical Spray Drying
Finding alternative solvent approaches could allow for lower volumes of less toxic solvents, significantly improving both the environmental and human health implications of new drugs produced.
-
Complex Molecules, Complex Problems
The support of an experienced CDMO is critical to overcoming complexity when working with highly potent APIs and when solving solubility challenges.
-
Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing
6/30/2025
Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.
-
Age-Appropriate Pediatric Formulation Development
1/27/2022
There is a significant variability in the pharmacokinetics of the same drug and dosage form between pediatric and adult populations, and the factors impacting drug bioavailability are different in children.